Gene · 8764
Papers3,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Single-Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer. | Adv Sci (Weinh) | 2023 | 36529697 | PubTator, text mining | PubMed |
| Expression and Clinical Significance of Various Checkpoint Molecules in Advanced Osteosarcoma: Possibilities for Novel Immunotherapy. | Orthop Surg | 2023 | 36519392 | PubTator, text mining | PubMed |
| Comprehensive analysis of immune cell infiltration and role of MSR1 expression in aneurysmal subarachnoid haemorrhage. | Cell Prolif | 2023 | 36515067 | PubTator, text mining | PubMed |
| Identification and validation of a novel prognostic model based on platinum Resistance-related genes in bladder cancer. | Int Braz J Urol | 2023 | 36512456 | PubTator, text mining | PubMed |
| Comparison of Proteomic Measurements Across Platforms in the Atherosclerosis Risk in Communities (ARIC) Study. | Clin Chem | 2023 | 36508319 | PubTator, text mining | PubMed |
| Psoriatic arthritis: review of potential biomarkers predicting response to TNF inhibitors. | Inflammopharmacology | 2023 | 36508130 | PubTator, text mining | PubMed |
| In situ follicular neoplasia in a young post-liver transplant patient. | Pathol Int | 2023 | 36504425 | PubTator, text mining | PubMed |
| Glioblastoma glycolytic signature predicts unfavorable prognosis, immunological heterogeneity, and ENO1 promotes microglia M2 polarization and cancer cell malignancy. | Cancer Gene Ther | 2023 | 36494582 | PubTator, text mining | PubMed |
| Normofractionated irradiation and not temozolomide modulates the immunogenic and oncogenic phenotype of human glioblastoma cell lines. | Strahlenther Onkol | 2023 | 36480032 | PubTator, text mining | PubMed |
| Lymphotoxin beta receptor signaling directly controls airway smooth muscle deregulation and asthmatic lung dysfunction. | J Allergy Clin Immunol | 2023 | 36473503 | PubTator, text mining | PubMed |
| Follicle Center Lymphoma (FCL) of the Lower Female Genital Tract (LFGT): A Novel Variant of Primary Cutaneous Follicle Center Lymphoma (PCFCL). | Am J Surg Pathol | 2023 | 36461146 | PubTator, text mining | PubMed |
| A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomas. | Leukemia | 2023 | 36460764 | PubTator, text mining | PubMed |
| Analysis and therapeutic targeting of the EP300 and CREBBP acetyltransferases in anaplastic large cell lymphoma and Hodgkin lymphoma. | Leukemia | 2023 | 36456744 | PubTator, text mining | PubMed |
| A non-neutralizing glycoprotein B monoclonal antibody protects against herpes simplex virus disease in mice. | J Clin Invest | 2023 | 36454639 | PubTator, text mining | PubMed |
| Follicular lymphoma and marginal zone lymphoma: how many diseases? | Virchows Arch | 2023 | 36394631 | PubTator, text mining | PubMed |
| Genomic Profiling Reveals Differences in Primary Central Nervous System Lymphoma and Large B-Cell Lymphoma, With Subtyping Suggesting Sensitivity to BTK Inhibition. | Oncologist | 2023 | 36342081 | PubTator, text mining | PubMed |
| Comprehensive analysis of the immunological implication and prognostic value of CXCR4 in non-small cell lung cancer. | Cancer Immunol Immunother | 2023 | 36308553 | PubTator, text mining | PubMed |
| Recent advances in cutaneous lymphoma-implications for current and future classifications. | Virchows Arch | 2023 | 36278991 | PubTator, text mining | PubMed |
| Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study. | Clin Cancer Res | 2023 | 36269794 | PubTator, text mining | PubMed |
| Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety. | Cancer Discov | 2023 | 36259971 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8764/papers?page=39